Can Disrupted Tissue Architecture Be Targeted Therapeutically?
Yes, targeting the disrupted tissue architecture in cancer has therapeutic potential. Strategies include inhibiting [angiogenesis](), modifying the [ECM](), and targeting specific signaling pathways involved in cell adhesion and migration. Therapies that normalize the tumor microenvironment can restore some aspects of normal tissue architecture, potentially improving the effectiveness of conventional treatments like chemotherapy and radiation.
